Treatment for traumatic optic neuropathy with mouse nerve growth factor：a meta-analysis / 国际眼科杂志(Guoji Yanke Zazhi)

ABSTRACT

AIM:To evaluate the efficacy of treating traumatic optic neuropathy( TON) with mouse nerve growth factor. METHODS: We searched the Cochrane Library, Pubmed, Medline, CNKI, Wanfang database and VIP to collect randomized controlled trials ( RCTs ) of using mouse nerve growth factor for TON. The quality of the included trials was assessed and poor-qualified trials were eliminated before the meta - analysis was conducted. RESULTS:Seven RCTs with a total of 399 eyes included were retrieved, and OR=3. 78 with a 95%CI of [ 2. 35, 6.06], the difference was significant (P CONCLUSION:The existing evidence supports that the prognosis of TON is better when mouse nerve growth factor are adopted in treatment, but there is still a need for well-planned, large-scale and multicenter RCTs to verify it.